-+ 0.00%
-+ 0.00%
-+ 0.00%

INNOVENT ANNOUNCES PECONDLE® (PICANKIBART INJECTION) PHASE 3 STUDY (CLEAR-2) MEETS ENDPOINTS, DELIVERING SUPERIOR LONG-TERM MANAGEMENT SOLUTION FOR MODERATE-TO-SEVERE PSORIASIS

Reuters·12/09/2025 00:00:00

Please log in to view news